Vivani Medical is developing an implant of semaglutide, the active ingredient in Novo Nordisk's obesity injection Wegovy and ...

Dr. Reddy's Laboratories (NYSE:RDY) said a scale-up issue tied to the active pharmaceutical ingredient for its semaglutide ...

Health Canada has approved the first generic semaglutide injection for weight loss.

By Rishika Sadam and Kashish Tandon July 9 (Reuters) - India's Dr Reddy's Laboratories said on Thursday that supplies of its ...

Indian pharma majors Sun Pharma, Dr Reddy's and Glenmark on Saturday announced the launch of their generic versions of ...

Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a once-weekly injection. It’s administered with a tiny needle that punctures ...

Two such prescription medications include dulaglutide (brand name Trulicity) and semaglutide (brand names Ozempic and Wegovy) ...

As demand for injectable weight-loss medicines grows, experts are urging South Africans to check whether their medication is SAHPRA-registered, warning that unregistered products may carry serious ...

The weight loss drugs landscape in the UK underwent a seismic shift on 6 July 2026 when Wegovy – an injectable semaglutide – ...

The recall affects only select 2 mg and 4 mg Semalix injection pens manufactured by Dr Reddy's Laboratories, while all other ...

Dr Reddy's shares remain under pressure after its semaglutide production halt. Here's what leading brokerages expect for ...